ICRF-193, a catalytic inhibitor of DNA topoisomerase II, inhibits re-entry into the cell division cycle from quiescent state in mammalian cells

Genes to Cells

Volumn 7, Issue 3, 2002, Pages 285-294

  Hossain, Muktadir S ^a   Akimitsu, Nobuyoshi ^a   Takaki, Tohru ^b   Hirai, Hiroshi ^b   Sekimizu, Kazuhisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; DNA TOPOISOMERASE (ATP HYDROLYSING); GYRASE INHIBITOR; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL GROWTH; CONTACT INHIBITION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; DRUG TARGETING; MAMMAL CELL; METAPHASE; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SPLEEN CELL;

3T3 CELLS; ANIMALS; CELL CYCLE; CELLS, CULTURED; CONTACT INHIBITION; DNA; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; ENZYME INHIBITORS; G0 PHASE; LIPOPOLYSACCHARIDES; MICE; NUCLEIC ACID SYNTHESIS INHIBITORS; PIPERAZINES; SPLEEN;

ANIMALIA; MAMMALIA; MURINAE;

EID: 0036201868     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.2002.00521.x     Document Type: Article

References (54)

1. Chromosome assembly in vitro: Topoisomerase II is required for condensation
2. Catalytic inhibitors of DNA topoisomerase II
3. Role of DNA topoisomerase II in chromosome dynamics in mammalian cells
4. Expression, domain structure, and enzymatic properties of an active recombinant human topoisomerase IIβ
5. Novel HeLa topoisomerase II is the IIβ isoform: Complete coding sequence and homology with other type II topoisomerases
6. Extensive unwinding of the plasmid template during staged enzymatic initiation of DNA replication from the origin of the Escherichia coli chromosome
7. Active DNA topoisomerase IIα is a component of the salt-stable centrosome core
8. Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks
9. DNA topoisomerase II mutant of Saccharomyces cerevisiae: Topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication
10. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
11. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II
12. In vitro assembly of a pre-priming complex of the origin of the Escherichia coli chromosome
13. Essential mitotic functions of DNA topoisomerase IIα are not adopted by topoisomerase IIβ in human H69 cells
14. Stimulation of DNA synthesis in quiescent cells
15. Topoisomerase II does not play a scaffolding role in the organization of mitotic chromosomes assembled in Xenopus egg extracts
16. DNA topoisomerase II is required at the time of mitosis in yeast
17. Physiological regulation of eukaryotic topoisomerase II
18. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae
19. Inhibition of intracellular topoisomerase II by antitumor bis (2,6-dioxopiperazine) derivatives: Mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors
20. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cellular events
21. Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro
22. Synthesis of simian virus 40 C-family catenated dimers in vivo in the presence of ICRF-193
23. Model system for DNA replication of a plasmid DNA containing the autonomously replicating sequence from Saccharomyces cerevisiae
24. Topoisomerase II plays an essential role as a swivelase in the late stage of SV40 chromosome replication in vitro
25. ICRF-193, a catalytic inhibitor of DNA topoisomerase II delays the cell cycle progression from metaphase but not from anaphase to the G1 phase in mammalian cells
26. Topoisomerase mutants and physiological conditions control supercoiling and Z-DNA formation in vivo
27. Heat shock-induced DNA relaxation in vitro by DNA gyrase of Escherichia coli in the presence of ATP
28. DNA supercoiling factor localizes to puffs on polytene chromosomes in Drosophila melanogaster
29. Functional dissection of DNA supercoling factor: EF-hand domains and C-terminal motif are essential for its activity
30. Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3′,5′-monophosphate response element-binding protein and related transcription factors
31. Chromosome architecture can dictate site-specific initiation of DNA replication in Xenopus egg extracts
32. Myc function and regulation
33. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic activities
34. Increase in negative supercoiling of plasmid DNA in Escherichia coli exposed to cold shock
35. Relaxation of supercoiled DNA associated with induction of heat-shock proteins in Escherichia coli
36. DNA topoisomerase IIα is required for RNA polymerase II transcription on chromatin templates
37. DnaK heat shock protein of Escherichia coli maintains the negative supercoiling of DNA against thermal stress
38. Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat-shock in Escherichia coli
39. Purification of a DNA supercoiling factor from the posterior silk gland of Bombyx mori
40. 2+-binding protein
41. Lovastatin mediated G1 arrest is through inhibition of the proteasome, independent of hydroxy methyl glutaryl-CoA reductase
42. Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp
43. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: A Tyr49Phe mutation confers high level resistance to bisdioxopiperazines
44. A nitrogen starvation-induced dormant G0 state in fission yeast: The establishment from uncommitted G1 state and its delay for return to proliferation
45. cdc dephosphorylation in DNA damage- and topoisomerase II inactivation-induced G2 arrests in HL-60 cells
46. ICRF-193, an inhibitor of DNA topoisomerase II, demonstrates that DNA replication in sperm nuclei reconstituted in Xenopus egg extracts does not require chromatin decondensation
47. Involvement of DNA topoisomerase IIβ in neuronal differentiation
48. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe
49. Isolation of type I and II DNA topoisomerase mutants from fission yeast: Single and double mutants show different phenotypes in cell growth and chromatin organization
50. DNA topoisomerases
51. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP domain of the α isoform
52. Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II
53. Lovastatin arrests CHO cells between the origin decision point and the restriction point
54. DNA topoisomerase IIβ and neural development